May 20, 2014 – Dr. L'Heureux to be the keynote speaker at the French National Meeting on Biomaterials Research ("Assises Nationales de la Recherche en Biomatériaux"; Autrans, France).
May 5, 2014 - Dr. McAllister to present Cytograft’s unique and successful business model at the Regenerative Medicine conference in San Francisco.  Program details can be found here.
April 27, 2014 – Dr. L'Heureux to present recent results regarding the use of "Cell-synthesized extracellular matrix particles for tissue engineering and aesthetic applications" at the Experimental Biology 2014 meeting in San Diego. Link to the published abstract in the FASEB Journal here.
April 25, 2014 - Dr. McAllister to present on the convergence of tissue engineering and bioprinting at the ISCT annual meeting. Meeting agenda is here.
March 16, 2014 – Dr. McAllister publishes a perspective manuscript in MedNous. Full text is available here.
March 14, 2014 – A patent application describing the new abdominal aorta aneurism (AAA) repair device created by Cytograft is published by the USPTO (Patent application 20140081385)
March 14, 2014 – Dr. L'Heureux to speak at the INSERM Workshop #226 "3D cell culture bridges the gap between cell culture and live tissue" (Bordeaux, France).
March 14, 2014 - Dr. McAllister presents data in an invited lecture at the Ohio State University wound Care Conference. Conference program can be found here.
October 28, 2013 – Dr. L’Heureux to hold a seminar at the Vascular Surgery Institute of Fudan University Medical School  (Shanghai, China). 
October 7, 2013 - Results from the "First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access" are published in the Journal of Vascular Surgery (available as Epub ahead of print). Link to publisher here.
December 5, 2013 - Drs. L’Heureux and McAllister publish in the 2012 World Stem Cell Report.  In this invited manuscript, Cytograft’s founders propose revised regulatory standards for autologous cell therapies.  See the full length manuscript in Regenerative Medicine here.
 
BOARD OF DIRECTORS
Todd McAllister portrait

Dr. Todd McAllister, Ph.D. - Chairman

Dr. McAllister received his Ph.D. in BioMedical Engineering from the University of California, San Diego. He is the co-founder and CEO of Cytograft Tissue Engineering, Inc. Dr. McAllister has been an early proponent of biological approaches to tissue engineering that do not require synthetic scaffolds. Dr. McAllister has also pioneered a novel business strategy within Regenerative Medicine, taking Cytograft’s lead product, the Lifeline™ Vascular Graft from inception to commercial licensure in Europe on less than $10M in private equity.

Dr. McAllister also served as Co-Director of the Center for Regenerative Medicine at the St. Joseph’s Translational Research Institute in Atlanta, where he oversaw a broader range of cell-based cardiovascular repair technologies. He also serves on several advisory boards, including Lumen, Biocardia, and the Medical University of South Carolina.

Nicolas L'Heureux Portrait

Dr. Nicolas L'Heureux, Ph.D.

Dr. L’Heureux received his Ph.D. in Cell Biology from Laval University in Quebec, Canada and was a post-doctoral AHA fellow in the Department of Bioengineering at the University of California, San Diego. He is the co-founder and CSO of Cytograft Tissue Engineering, Inc. Dr. L'Heureux invented Tissue Engineering by Self-Assembly (TESA), a novel tissue engineering strategy. He advocates a biological approach to Regenerative Medicine, minimizing the inclusion of synthetic scaffolds and exogenous biomaterials.

Dr. L'Heureux also served as Co-Director of the Center for Regenerative Medicine at the St. Joseph’s Translational Research Institute in Atlanta. As a co-director he oversaw research of cell-based cardiovascular repair technologies.

Robert J. Robbins portrait

Dr. Robert J. Robbins, MD.

Dr. Robert C. Robbins is the president and CEO of the Texas Medical Center. He attended the University of Mississippi Medical Center where he received his MD and completed his general surgical training. He completed his Cardiothoracic Surgery Residency at Stanford University.

In addition to his work at Texas Medical Center, Dr. Robbins is also a manuscript reviewer for a number of prestigious journals including the New England Journal of Medicine, Annals of Thoracic Surgery, and the Journal of Thoracic and Cardiovascular Surgery. He also serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery, Cardiac Surgery Digest, the Journal of Heart and Lung Transplantation, and Innovations. Jose M. Malbran Portrait

Jose M. Malbran

Jose Malbran has extensive experience in the private banking industry with significant regional exposure throughout Latin America, Europe, the Middle East and Africa. He has spent more than 30 years at Merrill Lynch in successive Private Client senior management roles including the Chairman of the the International Private Client Group.

Over the last 20 years, Mr. Malbran's leadership has fostered productivity and profitability. He has served as District Director for Southern Latin America, giving him the responsibility of overseeing the International Private Client business in Panama, Caracas, Sao Paulo, Montevideo, Santiago (Chile), as well as ML Banque Suisse in Montevideo. He has also served as chairman of International Private Client Group Latin America and became a member of the Executive Committee. Additionally, he held the position of Chairman of Merrill Lynch International Banks and participated in several investment banking deals, debt offerings and privatizations. He has also held the positions of Senior Vice President and member of the GPC Executive Committee, as well as Director of Merrill Lynch Cayman Bank and Trust Company. Ted Tussing Portrait

Ted Tussing

As Director for the Stanford Hospital Corporate Partners Program, Ted seeks to enhance strategic relationships with corporations, venture capitalist and entrepreneurs that generate financial resources, opportunities and alliances for Stanford University Medical Center. These relationships seek to accelerate the translation of technology solutions for improve patient care delivery, research processes and innovative medical education.

Ted led the University of Chicago’s Corporate Relations and New Initiatives efforts for the Graduate School of Business. In this role he initiated the development of the school’s global strategy and established partnerships and degree granting programs in Asia through strategic industry alliances and with the Monetary Authority of Singapore and Economic Development Board.

Ted is also an adviser, investor and board member for various early-stage technology ventures initiatives. He is a member of the Board of Directors of BioCardia-- http://www.biocardia.com/ Ted was a founder and board member of Ibrix, Inc, a rapidly scalable parallel computing file system available for cluster computing, grid computing, and enterprise computing environments (acquired by HP, Aug. '09).